跳至主要内容
临床试验/NCT05240040
NCT05240040撤回不适用

Radioembolization to Treat Primary and Metastatic Liver Tumors

Methodist Health System1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2016年4月26日最近更新:
适应症

试验速览

阶段
不适用
状态
撤回
入组人数
100
试验地点
1
主要终点
time to recurrence

研究概览

简要总结

The use of Radiospheres in the management of intrahepatic cholangiocarcinoma is largely unknown and not reported in the medical literature. Methodist Dallas Medical Center has a large volume of IR procedures with Radioembolization and the investigators feel it is imperative to understand the outcomes, risks and benefits of the therapy in order to formulate recommendation to other centers.

详细描述

A retrospective chart review of patients who have the diagnosis of intrahepatic cholangiocarcinoma. Only patients treated at MDMC are included and data will be obtained from Meditech and Epic. A non-identified database of cases with the diagnosis of intrahepatic cholangiocarcinoma already treated with radiospheres will be created and compared with cases treated by other means.

Intrahepatic cholangiocarcinoma is the second most common primary malignancy of the liver. The standard therapy has been resection but many cases are not resectable due to comorbidities or other poor surgical candidacy factors. Most of these patients end up getting chemotherapy which can be toxic and sometimes poorly tolerated. Intrarterial glass or resin radioembolization has been used and published from only 3 centers in the medical literature and it has been shown to be a reasonable alternative to the above options. At MDMC, this therapy has been used effectively and it is important to describe the investigator's experience.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with the diagnosis of intrahepatic cholangiocarcinoma from January 2006 until April 2017 at Methodist Dallas Medical Center (MDMC)
  • Patients 18 years old or older

排除标准

  • Patients without the diagnosis of intrahepatic cholangiocarcinoma
  • Patients under 18 years of age

结局指标

主要结局

time to recurrence

时间窗: January 2006 until April 2017

time to recurrence

review the outcomes of patients treated with radiospheres

时间窗: January 2006 until April 2017

Patient survival

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Treat Primary and Metastatic Liver Tumors | 临床试验